These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20949639)

  • 1. Mechanisms of genetic variation in polioviruses.
    Savolainen-Kopra C; Blomqvist S
    Rev Med Virol; 2010 Nov; 20(6):358-71. PubMed ID: 20949639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution and polymorphism of poliovirus genomes.
    Crainic R; Kew O
    Biologicals; 1993 Dec; 21(4):379-84. PubMed ID: 8024754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
    Friedrich F
    Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic features of polioviruses isolated in Tunisia, 1991-2006.
    Haddad-Boubaker S; Ben Yahia A; Bahri O; Morel V; Balanant J; Delpeyroux F; Triki H
    J Clin Virol; 2008 Feb; 41(2):81-6. PubMed ID: 18023246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutation and recombination variability of vaccine polioviruses isolated in Belarus (1960-1999)].
    Beletskaia TS; Samoĭlovich EO; Korotkova EA; Scheslenok EP; Fel'dman EV
    Mol Gen Mikrobiol Virusol; 2002; (1):24-31. PubMed ID: 11904921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengths and weaknesses of current polio vaccines--a view from industry.
    André FE
    Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
    Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
    Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic variability of Poliovirus: typing of strains isolated in Madagascar by restriction fragment length polymorphism (RFLP) assay].
    Razafindratsimandresy R; Rakoto Andrianarivelo M; Rousset D
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):27-32. PubMed ID: 15678812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new RT-PCR assay for the identification of the predominant recombination types in 2C and 3D genomic regions of vaccine-derived poliovirus strains.
    Pliaka V; Dedepsidis E; Kyriakopoulou Z; Mpirli K; Tsakogiannis D; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Mol Cell Probes; 2010 Jun; 24(3):115-23. PubMed ID: 19948215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Grabow WO; Ehlers MM
    Water Res; 2005 Sep; 39(14):3309-19. PubMed ID: 15996707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intertypic genomic rearrangements of poliovirus strains in vaccinees.
    Cammack N; Phillips A; Dunn G; Patel V; Minor PD
    Virology; 1988 Dec; 167(2):507-14. PubMed ID: 2849237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans.
    Friedrich F
    Acta Virol; 1998 Jun; 42(3):187-94. PubMed ID: 9842449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic recombination of poliovirus in a cell-free system.
    Duggal R; Cuconati A; Gromeier M; Wimmer E
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13786-91. PubMed ID: 9391105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference among deleterious mutations favours sex and recombination in finite populations.
    Keightley PD; Otto SP
    Nature; 2006 Sep; 443(7107):89-92. PubMed ID: 16957730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The two faces of mutation: extinction and adaptation in RNA viruses.
    Elena SF; Miralles R; Cuevas JM; Turner PE; Moya A
    IUBMB Life; 2000 Jan; 49(1):5-9. PubMed ID: 10772334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
    Kohara M; Abe S; Yoshioka I; Nomoto A
    Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating vaccine-derived polioviruses: current state of knowledge.
    Kew OM; Wright PF; Agol VI; Delpeyroux F; Shimizu H; Nathanson N; Pallansch MA
    Bull World Health Organ; 2004 Jan; 82(1):16-23. PubMed ID: 15106296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees.
    Karakasiliotis I; Markoulatos P; Katsorchis T
    Mol Cell Probes; 2004 Apr; 18(2):103-9. PubMed ID: 15051119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.